Systematic review exploring the clinical features of optic neuritis after SARS-CoV infection and vaccination
- PMID: 38057105
- PMCID: PMC10711871
- DOI: 10.1136/bmjophth-2023-001336
Systematic review exploring the clinical features of optic neuritis after SARS-CoV infection and vaccination
Abstract
Background: This study aims to characterise the symptoms and clinical features of optic neuritis (ON) following SARS-CoV-2 infection and vaccination.
Method: A literature search was conducted in four databases (PubMed, Medline, Embase and Google Scholar) to identify relevant case reports and case series. The records were screened and articles adhering to the inclusion criteria were critically appraised.
Results: Sixty-eight studies were found to be eligible for inclusion, including 34 reporting ON following SARS-CoV-2 infection and an equal number reporting cases postvaccination. In total 93 patients and 125 eyes were included. The infection cohort included 42 patients and 56 eyes, 51.2% were female and 33.3% experienced bilateral ON. The mean visual acuity was 1.64 log of minimum angle of resolution (LogMAR), while pain was present in 77.8%. Oligoclonal bands were present in 3 patients, myelin oligodendrocyte glycoprotein (MOG) antibodies in 18 patients and AQP-4 antibodies in 4 patients. The vaccination cohort included 51 patients and 69 eyes. 60.8% were female and 35.3% had a bilateral ON. The mean visual acuity was 0.93 LogMAR. Oligoclonal bands were present in 46.7%, MOG antibodies in nine patients and AQP-4 antibodies in three patients.
Conclusion: Patients with ON post-SARS-CoV infection were more likely to experience severe visual impairment than in cases following vaccination. Further research is required to outline the clinical features of ON after COVID-19 infection and vaccination, and establish causality.
Keywords: COVID-19; inflammation; optic nerve.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.J Neurol. 2022 Oct;269(10):5198-5212. doi: 10.1007/s00415-022-11194-9. Epub 2022 Jun 23. J Neurol. 2022. PMID: 35737110 Free PMC article. Review.
-
[Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].Zhonghua Yan Ke Za Zhi. 2019 Mar 11;55(3):174-179. doi: 10.3760/cma.j.issn.0412-4081.2019.03.005. Zhonghua Yan Ke Za Zhi. 2019. PMID: 30841683 Chinese.
-
Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.Indian J Ophthalmol. 2022 Jan;70(1):194-200. doi: 10.4103/ijo.IJO_887_21. Indian J Ophthalmol. 2022. PMID: 34937238 Free PMC article.
-
Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan.Ophthalmology. 2019 Oct;126(10):1385-1398. doi: 10.1016/j.ophtha.2019.04.042. Epub 2019 May 6. Ophthalmology. 2019. PMID: 31196727
-
Optic neuropathies post-Covid 19 - review.Rom J Ophthalmol. 2022 Oct-Dec;66(4):289-298. doi: 10.22336/rjo.2022.54. Rom J Ophthalmol. 2022. PMID: 36589322 Free PMC article. Review.
Cited by
-
Clinical characteristics of optic neuritis following COVID-19 during Omicron outbreak in China.Graefes Arch Clin Exp Ophthalmol. 2025 Jun;263(6):1701-1710. doi: 10.1007/s00417-025-06780-2. Epub 2025 Feb 21. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 39982475
-
A comparative study on anti-MOG and anti-AQP4 associated optic neuritis following mild COVID-19: insights from a Chinese single-center experience.Front Neurol. 2024 Jun 26;15:1416493. doi: 10.3389/fneur.2024.1416493. eCollection 2024. Front Neurol. 2024. PMID: 38988608 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous